Graham Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-83,876	Closed	-$654K	–	1180
2025 Q4	$654K	Sell	83,876 -183,854	-69%	-$1.33M	0.02%	527
2025 Q3	$2.03M	Buy	267,730 +48,646	+22%	+$405K	0.08%	231
2025 Q2	$1.96M	Buy	219,084 +82,981	+61%	+$773K	0.06%	364
2025 Q1	$1.02M	Buy	136,103 +38,846	+40%	+$313K	0.03%	542
2024 Q4	$731K	Buy	+97,257	New	+$738K	0.02%	592
2024 Q1	–	Sell	-64,856	Closed	-$388K	–	1064
2023 Q4	$388K	Buy	64,856 +27,330	+73%	+$158K	0.01%	662
2023 Q3	$266K	Sell	37,526 -111	-0.3%	-$798	0.01%	761
2023 Q2	$265K	Buy	+37,637	New	+$302K	0.01%	727
2022 Q4	–	Sell	-24,972	Closed	-$314K	–	1056
2022 Q3	$314K	Sell	24,972 -137,741	-85%	-$1.77M	0.01%	890
2022 Q2	$1.72M	Buy	+162,713	New	+$1.68M	0.08%	253